First-Line Sugemalimab Plus Chemotherapy for Advanced Gastric CancerXiaotian Zhang, Yanhua Chen, Qingxia Fan et al.|JAMA|2025Cited by 72
A Phase III, randomized, double-blind, placebo-controlled, multicenter study of fruquintinib in Chinese patients with advanced nonsquamous non-small-cell lung cancer – The FALUCA studyShun Lü, Weiguo Su, Gongyan Chen et al.|Lung Cancer|2020Cited by 21